Welcome to our dedicated page for Somalogic news (Ticker: SLGC), a resource for investors and traders seeking the latest updates and insights on Somalogic stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Somalogic's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Somalogic's position in the market.
CM Life Sciences II and SomaLogic, Inc. have received approval from the SEC for their business combination, with a special meeting for shareholders set for August 31, 2021. The planned transaction is expected to close soon thereafter. SomaLogic reported impressive preliminary revenue of approximately $19.7 million for Q2 2021, marking a 176% increase year-over-year, and $38.6 million for the first half, a 187% increase. Growth is attributed to a return to fee-for-service options, new pharma and research ventures, and royalties.
On August 12, 2021, SomaLogic announced that Melody Harris, its President and COO, has been honored as a 2021 C-Suite Award winner by the Denver Business Journal. This recognition highlights her leadership and contributions to the company's growth and innovation. CEO Roy Smythe praised her ability to develop strong teams and effective business structures. The C-Suite Awards celebrate executives who demonstrate exceptional leadership, risk management, and profitable growth, with Harris being recognized for her pivotal role at SomaLogic.
On August 2, 2021, SomaLogic announced the appointment of Shaun Blakeman as Chief Financial Officer. With over 20 years of experience, Blakeman previously held executive roles at Cantel Medical and Medtronic, strengthening SomaLogic's leadership. CEO Roy Smythe expressed confidence in Blakeman's impact as the company aims to scale its AI-driven proteomics technology. Blakeman holds advanced degrees in economics, applied physics, and business administration, and acknowledged the opportunity to enhance global healthcare outcomes.